List of Tables
Table 1. Global Adalimumab Biosimilar Sales (K MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Adalimumab Biosimilar Sales (K MT) Comparison by Application (2021-2027)
Table 3. Global Adalimumab Biosimilar Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Adalimumab Biosimilar Covered in This Study
Table 5. Global Adalimumab Biosimilar Sales (K MT) of Key Manufacturers (2016-2021)
Table 6. Global Adalimumab Biosimilar Sales Share by Manufacturers (2016-2021)
Table 7. Global Adalimumab Biosimilar Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Adalimumab Biosimilar Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Adalimumab Biosimilar Average Price (USD/MT) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Adalimumab Biosimilar Manufacturing Sites and Area Served
Table 11. Manufacturers Adalimumab Biosimilar Product Type
Table 12. Global Adalimumab Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Adalimumab Biosimilar by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Adalimumab Biosimilar as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Adalimumab Biosimilar Sales by Region (2016-2021) & (K MT)
Table 16. Global Adalimumab Biosimilar Sales Market Share by Region (2016-2021)
Table 17. Global Adalimumab Biosimilar Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Adalimumab Biosimilar Sales by Country (2016-2021) & (K MT)
Table 19. North America Adalimumab Biosimilar Sales Market Share by Country (2016-2021)
Table 20. North America Adalimumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Adalimumab Biosimilar Revenue Market Share by Country (2016-2021)
Table 22. Europe Adalimumab Biosimilar Sales by Country (2016-2021) & (K MT)
Table 23. Europe Adalimumab Biosimilar Sales Market Share by Country (2016-2021)
Table 24. Europe Adalimumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Adalimumab Biosimilar Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Adalimumab Biosimilar Sales by Region (2016-2021) & (K MT)
Table 27. Asia Pacific Adalimumab Biosimilar Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Adalimumab Biosimilar Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Adalimumab Biosimilar Revenue Market Share by Region (2016-2021)
Table 30. Latin America Adalimumab Biosimilar Sales by Country (2016-2021) & (K MT)
Table 31. Latin America Adalimumab Biosimilar Sales Market Share by Country (2016-2021)
Table 32. Latin America Adalimumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Adalimumab Biosimilar Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Adalimumab Biosimilar Sales by Country (2016-2021) & (K MT)
Table 35. Middle East and Africa Adalimumab Biosimilar Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Adalimumab Biosimilar Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Adalimumab Biosimilar Revenue Market Share by Country (2016-2021)
Table 38. Global Adalimumab Biosimilar Sales (K MT) by Type (2016-2021)
Table 39. Global Adalimumab Biosimilar Sales Market Share by Type (2016-2021)
Table 40. Global Adalimumab Biosimilar Revenue (Million US$) by Type (2016-2021)
Table 41. Global Adalimumab Biosimilar Revenue Share by Type (2016-2021)
Table 42. Global Adalimumab Biosimilar Price (USD/MT) by Type (2016-2021)
Table 43. Global Adalimumab Biosimilar Sales (K MT) by Application (2016-2021)
Table 44. Global Adalimumab Biosimilar Sales Market Share by Application (2016-2021)
Table 45. Global Adalimumab Biosimilar Revenue (Million US$) by Application (2016-2021)
Table 46. Global Adalimumab Biosimilar Revenue Share by Application (2016-2021)
Table 47. Global Adalimumab Biosimilar Price (USD/MT) by Application (2016-2021)
Table 48. AET BioTech Corporation Information
Table 49. AET BioTech Description and Business Overview
Table 50. AET BioTech Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 51. AET BioTech Adalimumab Biosimilar Product
Table 52. AET BioTech Recent Developments/Updates
Table 53. Amgen Corporation Information
Table 54. Amgen Description and Business Overview
Table 55. Amgen Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 56. Amgen Adalimumab Biosimilar Product
Table 57. Amgen Recent Developments/Updates
Table 58. Boehringer Ingelheim Corporation Information
Table 59. Boehringer Ingelheim Description and Business Overview
Table 60. Boehringer Ingelheim Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 61. Boehringer Ingelheim Adalimumab Biosimilar Product
Table 62. Boehringer Ingelheim Recent Developments/Updates
Table 63. Coherus Biosciences Corporation Information
Table 64. Coherus Biosciences Description and Business Overview
Table 65. Coherus Biosciences Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 66. Coherus Biosciences Adalimumab Biosimilar Product
Table 67. Coherus Biosciences Recent Developments/Updates
Table 68. Fujifilm Kyowa Kirin Biologics Corporation Information
Table 69. Fujifilm Kyowa Kirin Biologics Description and Business Overview
Table 70. Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 71. Fujifilm Kyowa Kirin Biologics Adalimumab Biosimilar Product
Table 72. Fujifilm Kyowa Kirin Biologics Recent Developments/Updates
Table 73. LG Life Sciences/Mochida Pharmaceutical Corporation Information
Table 74. LG Life Sciences/Mochida Pharmaceutical Description and Business Overview
Table 75. LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 76. LG Life Sciences/Mochida Pharmaceutical Adalimumab Biosimilar Product
Table 77. LG Life Sciences/Mochida Pharmaceutical Recent Developments/Updates
Table 78. Momenta Pharmaceuticals Corporation Information
Table 79. Momenta Pharmaceuticals Description and Business Overview
Table 80. Momenta Pharmaceuticals Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 81. Momenta Pharmaceuticals Adalimumab Biosimilar Product
Table 82. Momenta Pharmaceuticals Recent Developments/Updates
Table 83. Oncobiologics Corporation Information
Table 84. Oncobiologics Description and Business Overview
Table 85. Oncobiologics Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 86. Oncobiologics Adalimumab Biosimilar Product
Table 87. Oncobiologics Recent Developments/Updates
Table 88. Pfizer Corporation Information
Table 89. Pfizer Description and Business Overview
Table 90. Pfizer Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 91. Pfizer Adalimumab Biosimilar Product
Table 92. Pfizer Recent Developments/Updates
Table 93. Samsung Bioepsis Corporation Information
Table 94. Samsung Bioepsis Description and Business Overview
Table 95. Samsung Bioepsis Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 96. Samsung Bioepsis Adalimumab Biosimilar Product
Table 97. Samsung Bioepsis Recent Developments/Updates
Table 98. Sandoz Corporation Information
Table 99. Sandoz Description and Business Overview
Table 100. Sandoz Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 101. Sandoz Adalimumab Biosimilar Product
Table 102. Sandoz Recent Developments/Updates
Table 103. Zydus Cadila Corporation Information
Table 104. Zydus Cadila Description and Business Overview
Table 105. Zydus Cadila Adalimumab Biosimilar Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021)
Table 106. Zydus Cadila Adalimumab Biosimilar Product
Table 107. Zydus Cadila Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Adalimumab Biosimilar Distributors List
Table 111. Adalimumab Biosimilar Customers List
Table 112. Adalimumab Biosimilar Market Trends
Table 113. Adalimumab Biosimilar Growth Drivers
Table 114. Adalimumab Biosimilar Market Restraints
Table 115. Global Adalimumab Biosimilar Sales Forecast by Type (2022-2027) & (K MT)
Table 116. Global Adalimumab Biosimilar Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Adalimumab Biosimilar Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Adalimumab Biosimilar Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Adalimumab Biosimilar Sales Forecast by Application (2022-2027) & (K MT)
Table 120. Global Adalimumab Biosimilar Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Adalimumab Biosimilar Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Adalimumab Biosimilar Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Adalimumab Biosimilar Sales Forecast by Region (2022-2027) & (K MT)
Table 124. Global Adalimumab Biosimilar Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Adalimumab Biosimilar Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Adalimumab Biosimilar Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Adalimumab Biosimilar
Figure 2. Global Adalimumab Biosimilar Market Share by Type in 2020 & 2027
Figure 3. Tablet Product Picture
Figure 4. Oral Solution Product Picture
Figure 5. Global Adalimumab Biosimilar Market Share by Application in 2020 & 2027
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Global Adalimumab Biosimilar Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Adalimumab Biosimilar Market Size 2016-2027 (US$ Million)
Figure 11. Global Adalimumab Biosimilar Sales 2016-2027 (K MT)
Figure 12. Global Adalimumab Biosimilar Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Adalimumab Biosimilar Sales Share by Manufacturers in 2020
Figure 14. Global Adalimumab Biosimilar Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Adalimumab Biosimilar Players: Market Share by Revenue in 2020
Figure 16. Adalimumab Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Adalimumab Biosimilar Sales Market Share by Region (2016-2021)
Figure 18. Global Adalimumab Biosimilar Sales Market Share by Region in 2020
Figure 19. Global Adalimumab Biosimilar Revenue Market Share by Region (2016-2021)
Figure 20. Global Adalimumab Biosimilar Revenue Market Share by Region in 2020
Figure 21. U.S. Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Adalimumab Biosimilar Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Adalimumab Biosimilar by Type (2016-2021)
Figure 46. Sales Market Share of Adalimumab Biosimilar by Application (2016-2021)
Figure 47. Sales Market Share of Adalimumab Biosimilar by Application in 2020
Figure 48. Revenue Share of Adalimumab Biosimilar by Application (2016-2021)
Figure 49. Revenue Share of Adalimumab Biosimilar by Application in 2020
Figure 50. Manufacturing Cost Structure of Adalimumab Biosimilar
Figure 51. Manufacturing Process Analysis of Adalimumab Biosimilar
Figure 52. Adalimumab Biosimilar Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

LIST OF FIGURE

214